Act 657 - Emergency Medications

Act 657 of the 2024 Legislation Session allowed for the stocking of emergency medications by certain qualitied entities such as early learning centers, colleges and universities, restaurants, after-school programs, and others to be in a position to utilize such medications in emergencies. On April 1, 2025, the Louisiana Surgeon General issued standing orders for the distribution or dispensing of three emergency medications: albuterol, epinephrine, and naloxone. These medications are intended to support time-sensitive emergency medical situations, including acute allergic reactions (anaphylaxis), known or suspected opioid overdoses, and acute respiratory distress caused by asthma or allergic reactions. LDH is committed to supporting entities in their efforts to provide access to life-saving medications. 

---

---

---

---

Available for download are the following materials associated with these emergency medications:

• Standing orders for the distribution, dispensing, and administration of each emergency medication, issued by the Surgeon General;
• Medical protocols for the administration of naloxone, epinephrine, and albuterol as Life-Saving Emergency Medications; and
• A Dispensing Request Form for each medication, to be utilized by the entities wishing to stock these medications.

Contact

For questions or for additional guidance on securing and administering these medications, contact:
Dr. Jullette Saussy
Chief Medical Officer
LDH Office of Public Health
[email protected]

If entities have legal questions concerning the application or implementation of La. R.S. 40:1146, consult with your organization’s legal counsel.

---

---

---

---